company background image
JVC

Japan Vietnam Medical Investment and Development HOSE:JVC Stock Report

Last Price

₫5.79k

Market Cap

₫651.4b

7D

6.8%

1Y

35.3%

Updated

08 Aug, 2022

Data

Company Financials
JVC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

JVC Stock Overview

Japan Vietnam Medical Investment and Development Joint Stock Company engages in the supply and installation of medical equipment and devices.

Japan Vietnam Medical Investment and Development Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Japan Vietnam Medical Investment and Development
Historical stock prices
Current Share Price₫5,790.00
52 Week High₫14,200.00
52 Week Low₫4,000.00
Beta0
1 Month Change20.37%
3 Month Change-12.27%
1 Year Change35.28%
3 Year Change118.49%
5 Year Change42.96%
Change since IPO-67.51%

Recent News & Updates

Shareholder Returns

JVCVN HealthcareVN Market
7D6.8%0.7%3.7%
1Y35.3%-20.5%-7.0%

Return vs Industry: JVC exceeded the VN Healthcare industry which returned -20.5% over the past year.

Return vs Market: JVC exceeded the VN Market which returned -7% over the past year.

Price Volatility

Is JVC's price volatile compared to industry and market?
JVC volatility
JVC Average Weekly Movement9.2%
Healthcare Industry Average Movement5.2%
Market Average Movement7.4%
10% most volatile stocks in VN Market10.0%
10% least volatile stocks in VN Market4.2%

Stable Share Price: JVC is more volatile than 75% of VN stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: JVC's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of VN stocks.

About the Company

FoundedEmployeesCEOWebsite
2001n/aChung Lehttps://www.ytevietnhat.com.vn

Japan Vietnam Medical Investment and Development Joint Stock Company engages in the supply and installation of medical equipment and devices. It distributes medical equipment and consumables. It serves hospitals, health centers, and clinics.

Japan Vietnam Medical Investment and Development Fundamentals Summary

How do Japan Vietnam Medical Investment and Development's earnings and revenue compare to its market cap?
JVC fundamental statistics
Market Cap₫651.38b
Earnings (TTM)-₫31.69b
Revenue (TTM)₫499.43b

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
JVC income statement (TTM)
Revenue₫499.43b
Cost of Revenue₫405.45b
Gross Profit₫93.98b
Other Expenses₫125.68b
Earnings-₫31.69b

Last Reported Earnings

Mar 31, 2017

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did JVC perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is JVC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for JVC?

Other financial metrics that can be useful for relative valuation.

JVC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does JVC's PB Ratio compare to its peers?

JVC PB Ratio vs Peers
The above table shows the PB ratio for JVC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average9.7x
INDIES Indies Pharma Jamaica
4xn/aJA$4.2b
DNM DANAMECO Medical
0.8xn/a₫131.3b
3118 Level Biotechnology
1.6xn/aNT$869.7m
YIACO YIACO Medical Company K.S.C.P
32.3xn/aد.ك7.7m
JVC Japan Vietnam Medical Investment and Development
n/an/a₫651.4b

Price-To-Book vs Peers: Insufficient data to calculate JVC's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Earnings Ratio vs Industry

How does JVC's PE Ratio compare vs other companies in the Asian Healthcare Industry?

Price-To-Book vs Industry: Insufficient data to calculate JVC's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is JVC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

JVC PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate JVC's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of JVC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate JVC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate JVC's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

  • Take a look at our analysis of JVC's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Future Growth

How is Japan Vietnam Medical Investment and Development forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.8%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Japan Vietnam Medical Investment and Development has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of JVC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Past Performance

How has Japan Vietnam Medical Investment and Development performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


15.3%

Historical Healthcare annual earnings growth

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Japan Vietnam Medical Investment and Development has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Discover strong past performing companies

Financial Health

How is Japan Vietnam Medical Investment and Development's financial position?

Financial Health Score

0/6

Financial Health Score 0/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

In this section we usually analyse Japan Vietnam Medical Investment and Development's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Japan Vietnam Medical Investment and Development has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Discover healthy companies

  • Take a look at our analysis of JVC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Japan Vietnam Medical Investment and Development's financial data was last updated here.

Dividend

What is Japan Vietnam Medical Investment and Development current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate JVC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate JVC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if JVC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if JVC's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: JVC is not paying a notable dividend for the VN market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as JVC has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Chung Le

1.08yrs

Tenure

Mr. Chung Minh Le is Chief Executive Officer of Japan Vietnam Medical Investment and Development Joint Stock Company (Formally known as Japan Vietnam Medical Instrument Joint Stock Company) from July 13, 2...


Leadership Team

Experienced Management: JVC's management team is considered experienced (2.4 years average tenure).


Board Members

Experienced Board: JVC's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Japan Vietnam Medical Investment and Development Joint Stock Company's employee growth, exchange listings and data sources


Key Information

  • Name: Japan Vietnam Medical Investment and Development Joint Stock Company
  • Ticker: JVC
  • Exchange: HOSE
  • Founded: 2001
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: ₫651.376b
  • Shares outstanding: 112.50m
  • Website: https://www.ytevietnhat.com.vn

Location

  • Japan Vietnam Medical Investment and Development Joint Stock Company
  • Icon 4 building
  • 24th Floor
  • Hanoi
  • Vietnam

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/08 00:00
End of Day Share Price2022/08/08 00:00
Earnings2017/03/31
Annual Earnings2017/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.